ARCHIVES

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

This article is from The Cancer Letter archive.

Vol. 38 No. 07 | February 17, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Reynolds Retires “Joe Camel” advertising; Slaga Moves Lab To MC Cancer Center

July 18, 1997

University of Pittsburgh Cancer Institute Wins Core Grant Renewal

October 1, 2010

BSA Approves Trial of Carbon Ion Therapy, Extends EDRN And Provocative Questions

July 4, 2014

Brown’s appointment may Be Delayed Until After Jan. 20

January 14, 1977

Change In Method Of Counting Cancer Incidence Results In More Attributed To Work Hazards

October 6, 1978

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002